Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

DeCOG

5 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry